The 2026 Healthtech Messaging Index
Koda Health
kodahealthcare.com·scored August 23, 2026
26/38
Approaching
Close. The bones are good. A few targeted fixes on the weakest signals would push Koda Health into magnetic territory.
The AI Recommendation Check
When we asked AI who to recommend for Advance care planning software with EMR integration for health systems and payers, it named:
Buyer we put in the prompt: VP of Population Health, Chief Medical Officer, or Chief Strategy Officer at a health system, hospital, or Medicare Advantage payer. Both the buyer and the category were inferred from Koda Health’s homepage alone. The model had no web access.
Koda Health was not on the list.
A buyer who asked AI this question got 8 names and moved on. Koda Health never came up.
We asked AI who it recommends for "VP of Population Health, Chief Medical Officer, or Chief Strategy Officer at a health system, hospital, or Medicare Advantage payer" looking for "Advance care planning software with EMR integration for health systems and payers". It named Advance Care Planning Plus (ACP Decisions), Vynca, Vital Decisions, Conversations Ready (Ariadne Labs), Thoughtful. You did not appear. AI can't recommend what it can't clearly understand.
Overall assessment
Koda Health's biggest strength is its concrete proof ... ~40% cost reduction, 80 ... 85% completion rates, and 87 NPS give AI and human buyers specific, citable numbers that most competitors lack. The biggest gap is ICP clarity and alternatives acknowledgment: the page never names the specific buyer role, company size, or stage, and never addresses what buyers are doing instead of Koda, leaving a motivated buyer uncertain whether this is built for them and why switching matters now.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
12Alternatives Acknowledged
“No mention of competitors, alternative approaches, or 'do nothing' framing addressed to the buyer decision.”
The page never acknowledges that buyers could use paper-based processes, competing vendors, or in-house solutions ... alternatives are completely absent.
All 19 signals, scored 0 to 2.
Total 26/38
Narrative Clarity
8 signals
- 2
01The 7-Second Test
“Goals-aligned care ... for every patient, at scale. Turn patient preferences into clinical action with Koda's care planning platform.”
Within 7 seconds, a stranger understands this is a care planning platform that converts patient preferences into clinical action at scale ... clear who it's for, what it does, and its POV.
- 2
02Rebellion / Movement
“Serious illness planning is uncomfortable. Avoiding it is worse, leaving families with impossible decisions, providers without guidance, and patients' wishes unheard.”
The page explicitly names the status quo enemy ... avoidance of serious illness planning ... and articulates the harm it causes to all three stakeholders.
- 1
03Owned Language & Category
“Goals-aligned care" and "Kidney action planning”
"Goals-aligned care" and "Kidney action planning" hint at owned framing but aren't developed into a named category or coined framework an AI would exclusively attribute to Koda.
- 1
04ICP Clarity
“Koda brings patients, providers, and payors into alignment around a shared goal”
The page signals health systems, payers, and providers as buyers but never names a specific role (e.g., CMO, VP of Population Health), company size, or vertical, making ICP identification fuzzy.
- 2
05Problem Leadership
“Serious illness planning is uncomfortable. Avoiding it is worse, leaving families with impossible decisions, providers without guidance, and patients' wishes unheard.”
The page leads with the buyer's problem ... avoidance of serious illness planning and its downstream harm ... before pivoting to the solution.
- 2
06Solution Clarity
“digital infrastructure that captures serious-illness preferences and integrates them directly into the EMR, so the right information is there when it matters most”
A visitor can repeat in one sentence exactly what Koda does: digital platform that captures care preferences and pushes them into the EMR at point of care.
- 1
07Cost of Inaction
“Avoiding it is worse, leaving families with impossible decisions, providers without guidance, and patients' wishes unheard.”
The cost of inaction is implied emotionally but never quantified in business terms for the buyer ... no revenue impact, no penalty, no named operational cost of doing nothing.
- 1
08Promised Land
“moving care teams from reactive choices to consistent, goal-aligned decisions”
The promised land is sketched ... consistent, goal-aligned decisions ... but it's not painted as a vivid, specific 'after' state with concrete outcomes for the health system or payer buyer.
Trust Signal
4 signals
- 2
09Proof & Evidence
“~40% reduction in end-of-life costs" "80 ... 85% plan completion rates" "87 NPS”
Three concrete, specific metrics with real numbers anchor the proof section, moving well beyond adjectives into quantified outcomes.
- 1
10Social Proof
“J.B. Sobel, MD, MPH MBA ... Former CMO, Cigna Medicare Advantage" "William McKeon, MBA ... President & CEO, Texas Medical Center”
Named testimonials with titles exist and partner logos (UPMC, Houston Methodist, Sentara) are present, but there are no named case studies with before/after deltas or linked customer stories.
- 1
11Authority & Credibility
“Seeing Koda launch from our TMCi BioDesign program" ... William McKeon, Texas Medical Center”
The TMCi BioDesign mention adds credibility and there are senior-level endorsers, but no founder credentials, original research, frameworks, or published authority signals appear on the page.
- 0
12Alternatives Acknowledgedweakest
“No mention of competitors, alternative approaches, or 'do nothing' framing addressed to the buyer decision.”
The page never acknowledges that buyers could use paper-based processes, competing vendors, or in-house solutions ... alternatives are completely absent.
AI Signal
6 signals
- 1
13Customer Focus
“Koda identifies high-risk patients" "Koda's digital navigator guides patients" "Koda brings patients, providers, and payors into alignment”
The page mixes Koda-as-subject with customer outcomes; the protagonist shifts between Koda's capabilities and patient/provider benefit rather than centering the buyer's transformation throughout.
- 2
14AI-Parmesan Index
“No AI claims appear anywhere on the page; the word 'AI' does not appear in the content.”
Koda makes no AI claims at all, earning a clean score ... no AI-Parmesan sprinkled on weak narrative.
- 2
15LLM Quotability
“~40% reduction in end-of-life costs" "80 ... 85% plan completion rates across diverse populations" "87 NPS ... Patients feel supported, not managed.”
These declarative, specific sentences with numbers are cleanly quotable and citation-ready for an LLM recommending advance care planning platforms.
- 2
16Copyright Freshness
“Home[Michele Fog]2026-08-06T12:40:58-05:00" and "© 2026 Koda Health”
A 2026 copyright year and a visible August 2026 timestamp on the page metadata signal strong recency to AI crawlers.
- 2
17Entity Distinctiveness
“Automated 50-State Compliance" "80 ... 85% plan completion rates" "direct EMR integration" "Kidney action planning”
The combination of 50-state compliance automation, specific completion rates, kidney-specific planning, and named EMR integrations (Epic, Athena, Cerner) makes Koda distinctly identifiable ... swapping the logo would break the description.
- 0
18AI Recommendation Check
“AI's picks: Advance Care Planning Plus (ACP Decisions), Vynca, Vital Decisions, Conversations Ready (Ariadne Labs), Thoughtful, Five Wishes (Aging with Dignity). You were not named.”
We asked AI who it recommends for "VP of Population Health, Chief Medical Officer, or Chief Strategy Officer at a health system, hospital, or Medicare Advantage payer" looking for "Advance care planning software with EMR integration for health systems and payers". It named Advance Care Planning Plus (ACP Decisions), Vynca, Vital Decisions, Conversations Ready (Ariadne Labs), Thoughtful. You did not appear. AI can't recommend what it can't clearly understand.
Conversion Signal
1 signal
- 1
19Path & CTA Clarity
“Take a Tour" (primary CTA, appears twice) and "Watch Video" (secondary CTA)”
There is a primary CTA and a soft secondary, but no visible numbered process or steps showing what happens after clicking, so the path isn't fully connected.
Your move
Think Koda Health’s score is wrong? Good. Let’s look at it together.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Koda Health the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.
